Orchestra BioMed Holdings, Inc.
Filed with the SEC on · accession 0001104659-26-123304
OBIO filed a 424B5 (prospectus (offering)) with the SEC on Nov 5, 2026. Orchestra BioMed Holdings, Inc. filed a preliminary prospectus supplement (424B5) for a public offering of shares of its common stock, with Piper Sandler, TD Cowen, and BTIG acting as underwriters. The stock moved -6.3% by the first close after the filing.
Orchestra BioMed Holdings, Inc. filed a preliminary prospectus supplement (424B5) for a public offering of shares of its common stock, with Piper Sandler, TD Cowen, and BTIG acting as underwriters. The offering size, price, and use of proceeds are not yet specified in this preliminary filing.
Close before
$6.00
Nov 4, 2026
First close after
-6.33%
$5.62
5 trading days
—
Since filing
-5.00%
$5.70
✦ Ask GOAX AI about this filing — what it means for OBIO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for OBIO?
Click hereOBIO filed a 424B5 (Secondary offering). Orchestra BioMed Holdings, Inc. filed a preliminary prospectus supplement (424B5) for a public offering of shares of its common stock, with Piper Sandler, TD Cowen, and BTIG acting as underwriters. The offering size, price, and use of proceeds are not yet specified in this preliminary filing.
New shares dilute existing holders and are often sold at a discount to the market price.
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
OBIO closed at $6.00 before the filing and $5.62 on Nov 5, 2026 (-6.33%).
Get alerts when OBIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days